Genome Engineering Market : Future Demand and Growth Analysis
Due to the presence of a small number of leading international players and few regional players, the competitive rivalry in the global genome engineering market is expected to remain moderate, reports Transparency Market Research in a new study. The market is dominated by three leading companies, Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, and Sangamo Biosciences, Inc. These companies together accounted for 73.5% of the overall global revenue in 2014.
The emergence of small regional players in the genome engineering market has impelled the leading companies to focus on innovative product development. They are also focused on the development of differentiated products to maintain their lead in the global as well as regional markets. To produce innovative and technologically advanced products, companies are entering into agreements with research institutes and laboratories and investing in research and development projects. Browse the full Genome Engineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/genome-editing-engineering-market.html Pharmaceutical and Biotechnology Companies to Emerge as Largest End-use Segment Based on application, pharmaceutical and biotechnology companies accounted for 58% of the overall global revenue in 2014. Numerous applications of genome engineering in drug discovery and therapeutics contributed to the high growth of the segment. Moreover, the wide therapeutic use of genome engineering in the pharmaceutical industry is likely to drive its adoption in the coming years. The development of therapeutics models in genome engineering technology such as CRISPR technology and HIV using ZFN has impelled genome engineering companies to invest in advanced researches focusing on developing innovative techniques for genetic engineering. Academics emerged as the second largest segment in terms of application. Studies and research programs being conducted by academic institutions regarding the use of genome engineering